However, unlike KCTD15, it has been shown that KCTD1 is involved in proteasomal degradation processes, by complexing with other E3-ubiquitine ligases, through which it participates in negative regulation of pathways which are aberrantly activated in many human cancers [85]. Here, KCTD1 is linked to cancer.